SCYX vs NLSP
Comparison between Scynexis Inc (SCYX, Company) and NLS Pharmaceutics Ltd (NLSP, Company).
5-Year PerformanceSCYX has outperformed NLSP, delivering a return of -41.8% compared to -68.2%
SCYX vs NLSP - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
SCYX vs NLSP - Historical Returns
Returns include dividend reinvestment.
SCYX vs NLSP - Annual Returns (2014 - 2026)
Returns include dividend reinvestment.
| Year | SCYX | NLSP |
|---|---|---|
| 2026 | -26.98% | +60.83% |
| 2025 | -56.39% | -91.28% |
| 2024 | -45.25% | -91.03% |
| 2023 | +54.86% | -57.86% |
| 2022 | -76.58% | +8.40% |
| 2021 | -14.92% | -61.59% |
| 2020 | -14.72% | N/A |
| 2019 | +67.25% | N/A |
| 2018 | -78.87% | N/A |
| 2017 | -31.76% | N/A |
| 2016 | -47.70% | N/A |
| 2015 | -37.65% | N/A |
| 2014 | +10.89% | N/A |
SCYX vs NLSP Drawdown Comparison
The maximum drawdown for SCYX was -99.69%, occurring on Jul 27, 2026. This drawdown has not yet recovered.
The maximum drawdown for NLSP was -99.92%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The current SCYX drawdown is -99.68%. The current NLSP drawdown is -99.86%.
| Rank | SCYX | NLSP |
|---|---|---|
| #1 | -99.69% Jan 12, 2015 - Jul 27, 2026 | -99.92% Mar 12, 2021 - Mar 30, 2026 |
| #2 | -39.37% Jun 19, 2014 - Nov 21, 2014 | -35.41% Feb 11, 2021 - Mar 12, 2021 |
| #3 | -20.45% Nov 28, 2014 - Jan 9, 2015 | -9.34% Jan 29, 2021 - Feb 3, 2021 |
| #4 | -15.10% May 20, 2014 - Jun 16, 2014 | -7.69% Feb 4, 2021 - Feb 11, 2021 |
| #5 | -6.67% May 2, 2014 - May 9, 2014 | N/A |
| #6 | -3.33% May 9, 2014 - May 20, 2014 | N/A |
| #7 | -2.77% Jun 16, 2014 - Jun 19, 2014 | N/A |
| #8 | -0.50% Nov 24, 2014 - Nov 28, 2014 | N/A |
Correlation
Correlation between SCYX and NLSP is 0.93 which considered as a very strong positive correlation - the stocks move almost identically together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks